Final Conference Program - aatod

More documents

Recommendations

Info

Theodora Binion Taylor, ThD Illinois As a regulatory official, Dr. Binion Taylor has made great strides in integrating substance abuse, mental health, domestic violence, HIV/AIDS services, and child welfare throughout treatment services in Illinois. She increased technology utilization throughout Illinois’ treatment system to boost access to care and capture treatment outcome data. Dr. Binion Taylor supports training to assist providers in implementing evidence based treatment practices to enhance the quality of care for patients throughout Illinois. She is also a compassionate advocate for medication-assisted treatment and has fought tirelessly to reduce stigma and educate state leaders about the effectiveness of this treatment modality. During the past two years, Dr. Binion Taylor has successfully ensured medication-assisted treatment funding remains available, despite political pressure to reduce it. Friend of the Field Award Presented by Mark W. Parrino, MPA, AATOD President The prestigious Friend of the Field Award was established by the American Association for the Treatment of Opioid Dependence, Inc. Board of Directors. This award recognizes extraordinary contributions to the field of opioid treatment by an individual or institution whose work, although not directly related to methadone treatment, has had a significant impact on our field. The 2010 Friend of the Field Award has been awarded to: C. West Huddleston C. “West” Huddleston III, is the Chief Executive Officer of the National Association of Drug Court Professionals (NADCP). Prior to being appointed CEO, Mr. Huddleston served as the first Deputy Director and then Director of the National Drug Court Institute (NDCI) for nine years. During his 11 years of service at NADCP, Mr. Huddleston has delivered over 350 keynote speeches in 44 states and eight countries; authored 16 publications and briefs; developed and delivered 11 national training curricula; briefed numerous state legislatures, testified before U.S. Congress, and international Parliaments; and has been interviewed repeatedly by radio, television, and print media on topics related to alternative justice, alcohol and other drug abuse/dependence, drug policy, crime and public safety. Mr. Huddleston is regarded as a pioneer in drug courts and other alternative sentencing strategies having spent more than a decade providing vision and leadership throughout the world. Prior to his work at NADCP/NDCI, Mr. Huddleston worked for eight years as a board licensed clinician with misdemeanor and felony offenders at the county, state and federal levels. During this period, Mr. Huddleston worked throughout the Tennessee and Oklahoma justice systems to develop, implement and operate numerous offender-specific, in-custody and community mental health and substance abuse treatment pro - grams. Mr. Huddleston served as the director of two community corrections programs and as the interim director of a 125-bed pre-release correctional center. Mr. Huddleston serves as an advisor and/or consultant to the U.S. Department of Justice (DOJ), U.S. Department of Transportation (DOT), U.S. Department of Health and Human Services (HHS), Drug Enforcement Administration (DEA), White House Office of National Drug Control Policy (ONDCP), United Nations Office of Drugs and Crime (UNODC), the Organization of American States (OAS) and as a distinguished faculty member of the National Judicial College. Richard Lane/Robert Holden Patient Advocacy Award Presented by Joycelyn Woods, MA and Walter Ginter, CMA Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first methadone treatment programs. In 1974, he became the Executive Director of Man Alive and later served as Vice President of the American Methadone Treatment Association and as Vice Chairman of the Governor’s Council on Alcohol and Drug Abuse in Maryland. Mr. Lane was a passionate advocate for methadone treatment and, by disclosing his own treatment experiences, provided inspiration to patients and colleagues alike. Robert Holden was also a recovering heroin user, who later became the Director of PIDARC, an outpatient methadone treatment program in the District of Columbia. He later served as the Vice President of the American Association for the Treatment of Opioid Dependence, succeeding Richard Lane’s term of office. This award was established in 1995 and recognizes extraordinary achievements in patient advocacy. Lisa Mojer-Torres, JD Ms. Torres’ contributions, in her community and nationally, have had an immense impact on awareness of medication-assisted treatment and recovery. She is a tireless advocate for the dignity and rights of people seeking care and in long-term recovery from addiction herself. Ms. Torres is currently the Consumer and Recovery Advocate for New Jersey’s Division of Addiction Services and through this position works to bring the voices of people receiving services into all aspects of the Division’s activities. She has developed and presented trainings to the public that integrate her personal recovery experiences with the need for transformation of systems of care centered on the rights and needs of individuals. She sits on many recovery oriented committees, boards, and has held multiple national advisory board positions. The 2010 Awards Banquet Tuesday, October 26, 2010 Supported through a grant from Mallinckrodt (a Covidien Company). 20
Conference Sessions Wednesday, October 27, 2010 Wednesday Continental Breakfast 7:00 a.m.–8:00 a.m. Continental Ballroom Foyer WORKSHOP SESSIONS 8:00 a.m.–9:30 a.m. E1 Building Effective Therapeutic Partnerships Within Opioid Agonist Treatment Continental A Robert C. Lambert, MA, Program Director, Connecticut Counseling Centers, Inc., Norwalk, CT Research indicates that the quality of the therapeutic relationship has a greater effect on patient retention and outcomes then the specific counseling approach used. This “basic track” workshop will focus on the essential fundamental counseling skill of forming and maintaining the therapeutic relationship and the unique challenges involved in enhancing the therapeutic alliance with medicationassisted patients within the clinical setting. A key area of focus will be counselor expectancy as a therapeutic factor. Boundary issues specific to the counselor in recovery will also be explored. The presenters will discuss methods to enhance the quality of the therapeutic alliance. * Note: Basic Track E2 Using Data From the REMAS Study to Assist Counselors in Promoting Sexual Risk Reduction Continental B Donald Calsyn, PhD, Alcohol & Drug Abuse Institute, University of Washington, Seattle, WA Robert Sterling, PhD, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA Stephen Weinstein, PhD, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA Findings from the Real Men Are Safe (REMAS) study will be presented with an emphasis on results concerning engaging in sex under the influence of drugs or alcohol. Suggestions about how findings from REMAS can be integrated into counseling sessions will be presented. Despite the REMAS intervention being associated with sexual risk reduction and identified by the CDC as a promising evidenced based HIV prevention intervention, few programs are using REMAS materials. Possible reasons for low adoption will be proposed and attendees will be led in a discussion of what would be needed to increase adoption of REMAS. E3 PCSS-Mentoring Network for OTPs: Safe Use of Methadone and Buprenorphine Boulevard Room Andrew Saxon, MD, University of Washington, Seattle, WA Gavin Bart, MD, Director of the Division of Addiction Medicine at Hennepin County Medical Center, Minneapolis, MN Trusandra Taylor, MD, Medical Director, JEVS Human Services, Philadelphia, PA This workshop describes the Physician Clinical Support Systems (PCSS) for Buprenorphine and Methadone, two related SAMHSA/CSAT funded networks of mentors who provide education and support to clinicians prescribing buprenorphine and/or methadone. The workshop offers an overview of the PCSS, describes its website, guidances and other resources, and discusses the policy implications of this peer education strategy for OTPs and beyond. Sponsored by the Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment (SAMHSA/CSAT). AMA PRA Category 1 Credit approved. E4 Can You Watch My Kids While I Get Medicated Removing Barriers to Treatment Continental C Jeneane Burke, MSN, Thomas Jefferson University, Philadelphia, PA Colleen Maguire, MHS, Thomas Jefferson University, Philadelphia, PA The majority of female patients receiving MAT are single mothers with few supports. Lack of safe childcare is a major barrier to entering, engaging and/or remaining in treatment. The presenters will share evidence on the need for childcare during MAT, benefits of an on-site service and elements of Women’s Centered Treatment. They will describe their clinic’s Parent Child Center (PCC): staffing, funding, infection control measures, developmentally appropriate programming, assessment/referral of at risk children, communication from PCC to the treatment team, acclimation of children to the PCC and how the PCC is linked into the parents’ treatment program. E5 Innovative Group Treatment in an Outpatient Opioid Replacement Therapy Grand Ballroom Elizabeth Bredin, LICSW, Program Director, Bay Cove Treatment Center, Boston, MA Julia Carlson, LICSW, Senior Clinician, Bay Cove Treatment Center, Boston, MA The Bay Cove Treatment Center is a clinically-oriented methadone program treating dual-diagnosed patients. The treatment contract includes one individual and at least one group session weekly, daily October 23–27, 2010 | Hilton Chicago, Chicago, Illinois 21
Page 1 and 2: NATIONAL CONFERENCE Building Partne
Page 3 and 4: LETTER FROM THE CONFERENCE CHAIR De
Page 5 and 6: Pre-Conference Sessions Saturday, O
Page 7 and 8: MODULE DESCRIPTIONS Module One: Int
Page 9 and 10: The session also provides nurses wi
Page 11 and 12: disorders, medical care and vocatio
Page 13 and 14: Southwest Hall 16 Sex and Drug Usin
Page 15 and 16: presented will include neonatal and
Page 17 and 18: This workshop will preview and disc
Page 19 and 20: will discuss the collaborative proc
Page 21: with serum levels, and collaborativ
Page 25 and 26: F5 Using Patient Chart Audits to Im
Page 27 and 28: ecap and a valuable training tool t
Page 29 and 30: Sweet Home Chicago “C’mon, Oh b
Page 31 and 32: Alkermes, Inc. is a fully integrate
Page 33 and 34: medical, social, and public health
Page 35 and 36: Continuing Education SAMHSA is a pu

Final Conference Program - aatod

Create successful ePaper yourself

Delete template?

Save as template?